HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Business (Health)

Set Alert for Business {Health}

Takeda Offloads Emerging Market OTCs to Acino

Takeda is shedding some unwanted OTC assets in a number of emerging markets as part of its efforts to pay down debt and focus its portfolio following its acquisition of Shire. 

Deals Emerging Markets Business Strategies

Tylenol Relieves Pain For J&J Consumer As Baby Care Relaunch Loses Steam

Tylenol brand boosts J&J US OTC sales 8.4% to $477m, helping balance a 24.1% decline in baby care sales due to restocking reformulated Johnson’s Baby line in 2018, mostly in the US. Firm reports consumer health sales in the US were up 1.7% to $1.39bn.

OTC Drugs Sales & Earnings Commercial

French OTC Industry Warns Over-Regulation Is Threatening Its Future

Plans to move ibuprofen, aspirin and paracetamol OTCs behind the counter in French pharmacies will harm the country's self-medication industry, which is already lagging behind its European neighbors, warns local association Afipa.

France OTC Drugs Regulation

Deals

Set Alert for Deals {Health}

Latest From Health & Deals

Galenica Expands Swiss OTC Offering Through Hedoga Acquisition

Galenica has reinforced its position as the leading player in the Swiss OTC market through the acquisition of Hedoga Group,

Switzerland Health

RB Coughs Up For Digital Diagnostic Development

Reckitt will work with former Sanofi partner ResApp to develop a consumer app which can diagnose common respiratory issues. The partnership represents RB's latest move into the digital space for its Health business.

Digital Health OTC Devices

Perrigo Moves Closer To Exclusive Consumer Focus With UK Rx Generics Business Sale

Perrigo’s ambitions to become a consumer-focused company are a step closer after the firm announced an immediate sale of a ‘non-core’ asset.

Commercial Generic Drugs
See All

Strategy

Set Alert for Business Strategy {Health}

Latest From Health & Business Strategies

COVID-19 Consumer Health Market: Germ-Blocking Nasal Spray, 99.99% Effective Sanitizer, ‘Mask’ To Moisturize Hands

Sensory Cloud’s small study showed FEND nasal solution cut by 99% exhalation of bioaerosol to block COVID-19. Global BioProtect’s hand sanitizer with proprietary antibacterial technology eliminates 45 bacteria, fungi and virus. Trilogy Labs’  solution replenishes moisture in hands irritated by sanitizers.

OTC Drugs Coronavirus COVID-19

With Pataday Extra Strength, Alcon Eyes Consumers Looking For OTC 24-Hour Eye Allergy Remedy

Pataday Once Daily Relief Extra Strength is the same formulation as Novartis' Rx Pazeo. It will be the first OTC eye drop indicated for allergy itch with 24-hour efficacy, available online in September and through retailers in early 2021.

Prescription To Otc Switch FDA

US Appropriators Question FDA’s OTC Switch Process Overhaul, Homeopathic Market Oversight

Appropriations Committee’s report with Agriculture, Rural Development, FDA and Related Agencies FY2021 budget bill also reiterated concern about adding acetaminophen dosing information for children to OTC monograph. But its mentions of FDA initiative to expand ingredients available OTC and homeopathic market oversight were firsts.

Prescription To Otc Switch Legislation
See All

Sales & Earnings

Set Alert for Sales & Earnings {Health}

Latest From Health & Sales & Earnings

Taisho Boosted By Acquisitions As Japanese Business Struggles

Acquiring France's UPSA helped to lift Taisho's sales in the 12 months ended 31 March 2020, as its domestic Japanese business faltered.

Sales & Earnings Japan

COVID Who? CBD Leader Charlotte’s Web Maintains FY 2020 Guidance Of Growth Up To 20%

Charlotte’s Web is strengthening its DTC lead while growing its brick-and-mortar retail business, accelerating its pet product distribution and working to close its Abacus Health acquisition announced in March. The Boulder, CO-based CBD product manufacturer posted a 1% decline in net sales for the first quarter, but expects a rapid escalation in the second half of the year.

United States Coronavirus COVID-19

Bausch Will Look At Selling Eye Care Business If It Doesn't See Increase In Overall Valuation

CEO Joseph Papa says firm isn’t valued equal to sum of its parts. "If some of the parts don't seem to make sense or don't seem to be capturing the full value of a business,” Bausch “will look at all the alternatives for looking at things like spin-offs of parts of the business,” he says.

Business Strategies M & A
See All

Litigation

Set Alert for Legal Issues {Health}

Latest From Health & Legal Issues

GermBloc Hand-Sanitizer Class Action Takes Aim At 99.99% Germ-Killing Claim

Like other hand sanitizer manufacturers, WillSpeed Technology claims its GermBloc “kills 99.99% of germs.” Plaintiffs in a proposed class action filed in Massachusetts federal court allege the claim “grossly overstates” the product’s efficacy, deceiving consumers and endangering them with false confidence.

United States Legal Issues

Court’s Rejection Of Evidence Countering ‘Willful’ Deception On Talc Ends J&J’s Appeal Streak

Johnson & Johnson failed to convince a Missouri appeals court to overturn a lower court finding that plaintiffs presented clear and convincing evidence the talc in its Johnson’s Baby Powder causes ovarian cancer and that the firm knew and improperly influenced regulators to allow use of the ingredient.

Legal Issues Ingredients

J&J’s $4.69Bn Damages From Missouri Trial On Talc-Cancer Link Cut In Half, But Verdict Upheld

J&J’s appeal of largest verdict yet in complaints challenging safety of talc in its Johnson’s Baby Powder and Shower to Shower Shimmer products failed, but a Missouri court cut its damages by more than half. Missouri appellate panel says the firm should pay $500m compensatory and $1.62bn punitive damages.

United States US States
See All
UsernamePublicRestriction

Register